Fred B. Craves, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 43,503 shares at $210.99 ($9.3M) on 2024-05-14, disclosed to the SEC on 2024-05-16.
Scheduled sale ($9.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $210.99 | 8,827 | $1.9M | 20.1% |
| 2 | $210.99 | 8,827 | $1.9M | 20.1% |
| 3 | $211.84 | 5,009 | $1.1M | 11.5% |
| 4 | $211.84 | 5,009 | $1.1M | 11.5% |
| 5 | $212.85 | 1,363 | $290K | 3.1% |
| 6 | $212.85 | 1,363 |
| $290K |
| 3.1% |
| 7 | $213.85 | 2,190 | $468K | 5.1% |
| 8 | $213.85 | 2,190 | $468K | 5.1% |
| 9 | $214.68 | 1,804 | $387K | 4.2% |
| 10 | $214.68 | 1,804 | $387K | 4.2% |
| 11 | $216.08 | 375 | $81K | 0.9% |
| 12 | $216.98 | 721 | $156K | 1.7% |
| 13 | $216.98 | 721 | $156K | 1.7% |
| 14 | $217.86 | 1,100 | $240K | 2.6% |
| 15 | $217.86 | 1,100 | $240K | 2.6% |
| 16 | $218.99 | 1,000 | $219K | 2.4% |
| 17 | $219.90 | 100 | $22K | 0.2% |
| Total | $212.69 avg | 43,503 | $9.3M | 100% |
| Filing → |
| MDGL | SELL | 2024-11-27 | $1.2M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |
| MDGL | SELL | 2019-12-13 | $253.1M | — | Filing → |